Isoquercitrin clinical trials
Also written IQC-950AN and quercetin-3-O-glucoside.
Its developmentBy Quercis Pharma and AB Science, step by step2 company-led studies, furthest phase 3: when each phase was reached, its deals, target and what is ahead.How each study uses isoquercitrin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the isoquercitrin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2016 (3)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 9
Jeffrey Zwicker, MD (2) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Tulane University (1) · Memorial Sloan Kettering Cancer Center (1) · Quercis Pharma AG (1) · AB Science (1) · Nepal Health Research Council (1) · Consorzio Oncotech (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test isoquercitrin, phase 3 first.
- Oct 2027The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic CancerPhase 3 · Quercis Pharma AG
Studies
Open first, then newest update. How each study uses isoquercitrin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 11
- A Study of Isoquercetin in People With Ovarian CancerRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT07303894Written as Isoquercetin
- The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic CancerRecruitingPhase 3Quercis Pharma AGNCT06861088Written as Kinisoquin™
- Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19WithdrawnPhase 2Institut de Recherches Cliniques de MontrealNCT04536090Written as Isoquercetin (IQC-950AN)
- Fixed Dose Flavonoid Isoquercetin on Thrombo-Inflammatory Biomarkers in Subjects With Stable Sickle Cell DiseaseCompletedPhase 2National Heart, Lung, and Blood Institute (NHLBI)NCT04514510Written as Isoquercetin
- Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19Status unknownPhase 2AB ScienceNCT04622865Written as Isoquercetin
- Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) TrialCompletedPhase 2Tulane UniversityNCT02552888Written as Isoquercetin
- Cancer Associated Thrombosis and Isoquercetin (CATIQ)CompletedPhase 2/3Jeffrey Zwicker, MDNCT02195232Written as Isoquercetin
- Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19Status unknownPhase 2Nepal Health Research CouncilNCT04733651Written as Isoquercetin
- Isoquercetin in Sickle Cell AnemiaWithdrawnPhase 2Jeffrey Zwicker, MDNCT04474626Written as Isoquercetin
- Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II TrialStatus unknownPhase 1/2Consorzio OncotechNCT02446795Written as Isoquercetin
- Impact of isoQUercetin and Aspirin on Platelet FunctionWithdrawnNot applicableUniversity of ReadingNCT02866448Written as Isoquercetin
Codes
What other systems call isoquercitrin · ClinicalTrials.gg INT002652
- MeSH (NLM) C016527isoquercitrinOne source NLM
- UNII (FDA) 0YX10VRV6JISOQUERCITRINConfirmed FDA, NLM, Wikidata
- Wikidata Q27103621isoquercitrinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C99879IsoquercitrinOne source FDA
- DrugBank DB16403One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C016527 | isoquercitrin | One source NLM |
| UNII (FDA) | 0YX10VRV6J | ISOQUERCITRIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27103621 | isoquercitrin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C99879 | Isoquercitrin | One source FDA |
| DrugBank | DB16403 | — | One source Wikidata |
Also registered as isoquercetin (UNII 6HN2PC637T).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.